Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

300.83
-7.1700-2.33%
Post-market: 297.00-3.8300-1.27%17:34 EDT
Volume:954.85K
Turnover:289.02M
Market Cap:39.22B
PE:-143.37
High:310.22
Open:309.00
Low:300.27
Close:308.00
Loading ...

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Alnylam Pharma (ALNY)

TIPRANKS
·
29 Apr

Alnylam's Transthyretin Amyloidosis Drug Gets Positive Opinion From European Medicines Agency

MT Newswires Live
·
28 Apr

BRIEF-Alnylam Receives Positive CHMP Opinion For Vutrisiran For The Treatment Of Attr Amyloidosis With Cardiomyopathy

Reuters
·
28 Apr

Alnylam Pharmaceuticals Inc - European Commission Decision on Vutrisiran Expected June 2025

THOMSON REUTERS
·
28 Apr

Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Business Wire
·
28 Apr

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline

Zacks
·
24 Apr

U.S. RESEARCH ROUNDUP-Lowe's, Netflix, Vulcan Materials

Reuters
·
21 Apr

Alnylam Pharmaceuticals Inc : Jefferies Raises Target Price to $329 From $325

THOMSON REUTERS
·
21 Apr

BofA Adjusts Price Target on Alnylam Pharmaceuticals to $328 From $325, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Press Release: Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Dow Jones
·
17 Apr

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?

Insider Monkey
·
15 Apr

High Growth Tech Stocks In US With Potential For Expansion

Simply Wall St.
·
15 Apr

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs -- Heard on the Street -- WSJ

Dow Jones
·
11 Apr

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?

Zacks
·
10 Apr

Alnylam Pharmaceuticals Price Target Maintained With a $320.00/Share by Needham

Dow Jones
·
09 Apr

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?

Insider Monkey
·
09 Apr

Alnylam Pharma (ALNY) Receives a Buy from RBC Capital

TIPRANKS
·
05 Apr

Top Analyst Reports for Broadcom, UnitedHealth & Toyota Motor

Zacks
·
05 Apr

Canaccord Genuity Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
04 Apr

Alnylam Pharmaceuticals Price Target Maintained With a $500.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr